Going Digital – What Indian Pharma C-Suite has to Say

Any transformational initiative must be driven by the CEO and the leadership team.

The current efforts by Indian Pharma companies to adopt digital, leaves much to be desired. They are tactical in nature, a knee jerk response to address the challenges brought in Covid19 that made large field force to sit at home – something they have never done before.

So, the digital initiatives lacked strategic intent ans were at tactical at best as effort to enable the field force people to connect with doctors and invite them to a myriad of webinars via WhatsApp and emails.

The continuing uncertainty of Covid19 has made it clear that adopting digital is no longer a piecemeal campaign but a transformational exercise that needs to put the doctors and all other stakeholders at the centre.

Indian Pharma needs a robust Marketing Strategy that takes to account the changes in customer behavior, before going in for digital transformation.

As part o the 10th Anniversary Celebrations, MedicinMan brought together Pharma CEOs and senior industry leaders via four CEO Roundtable discussions for the benefit of Indian Pharma people.

The 1st CEO Roundtable was held in February 2021 with P V Sankar Dass, CEO of Curatio Healthcare, Tony Parmar, MD of Albert David, Peter Velev, CEO of Ecopharm, Bulgaria, Silviya Aleksandrova, COO of #CredoWeb and Deep Bhandari, Editorial Board Member, MedicinMan.

The second CEO Roundtable was held in October 2021 with Rajaram Narayanan, Managing Director, Sanofi India, delivering the Keynote Address. Panel Members: Atish Majumdar – President, Mankind Pharma Praful Akali, CEO – Medulla Communications Shireesh Sahai, CEO, – Wolters Kluwer India and Praful Akali, MD at Medulla Communications.

The third CEO Roundtable was held in November 2021 with Dr. Mahender Nayak, Senior VP / Head of ICMEA* Region (India, Turkey, CIS Countries, Ukraine, Middle East & Africa) at Takeda Pharmaceuticals, delivering the Keynote Address . Panel Members: Prakash Maheshwari, Vice President, Strategic Leadership at Glenmark. Sourabh Agrawal, Vice President – Sales & Marketing at Lupin Global. Salil Kallianpur, Executive Editor of MedicinMan and former Executive VP – Emerging Markets at GSK. Praful Akali, MD at Medulla Communications.

The forth and final CEO Roundtable 2021 series was held in December 2021 with Sanjiv Navangul delivering the Keynote Address. Panel Members: Sudip Chakraborty, Head- Strategic Engagement & Neurology Network, Europe at UCB Biopharma S/A, Brussels, Belgium. Amlesh Ranjan – Deputy Director, Super-specialty, Sanofi India. Aparna Mittal – Founder and CEO at PatientsEngage, Singapore. Salil Kallianpur, Executive Editor of MedicinMan and former Executive VP – Emerging Markets at GSK.

We trust that the experience and insights of these pharma leaders will enable Indian Pharma people to undertake the Digital Transformation journey in their companies.

MedicinMan will be following up the CEO Roundtable series with Pharma L&D Leadership Series discussions as they will be playing a crucial role in up-skilling pharma people with the right mindset and digital tools.

Is Pharma Sales Training Adapting to the Changed Market Reality?

Join the panel discussion with Deep Bhandari and Arun Subramanian with Anup Soans as moderator on the impact of the pandemic on pharma sales and the importance of sales enablement for the reps in the pharma industry.

Register to get your invitation by email – https://lnkd.in/gxNaPxkr.